All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
NLS PHARMACEUTICS LTD. Last Reported: 12/31/2023 Stock Symbol: NLSP

Business Address

THE CIRCLE 6
8058
ZURICH , CH CH-6370

Mailing Address

THE CIRCLE 6
8058
ZURICH , CH CH-6370
Phone Number: 41-41-618-80-00 / State Incorporated: / Fiscal Year End 12 /31

Balance Sheet

Date 12/31/2023 6/30/2023 12/31/2022 6/30/2022 12/31/2021 6/30/2021 12/31/2020 6/30/2020 12/31/2019 3/31/2019 12/31/2018 12/31/2017
Cash and Cash Equivalents $897,680.00 $1,651,452.00 $8,948,400.00 $1,354,187.00 $5,431,202.00 $7,092,115.00 $93,711.00 -- $220,267.00 -- -- --
Accounts Receivable Net Current -- -- -- -- -- -- -- -- -- -- -- --
Inventory -- -- -- -- -- -- -- -- -- -- -- --
Prepaid Expenses and Other Current Assets $925,382.00 $593,738.00 $297,998.00 $668,321.00 $291,954.00 $1,149,247.00 $103,000.00 -- $161,479.00 -- -- --
Total Current Assets $1,823,062.00 $2,245,190.00 $9,246,398.00 $2,022,508.00 $5,723,156.00 $8,241,362.00 $196,711.00 -- $381,746.00 -- -- --
Property Plant and Equipement $6,694.00 $12,398.00 $18,102.00 $23,806.00 $29,510.00 $27,733.00 -- -- -- -- -- --
Intangible Assets Net -- -- -- -- -- -- -- -- -- -- -- --
Goodwill -- -- -- -- -- -- -- -- -- -- -- --
Other Assets $16,885.00 $12,558.00 $12,143.00 $11,735.00 $12,044.00 -- -- -- -- -- -- --
Total Assets $1,846,641.00 $2,270,146.00 $9,276,643.00 $2,058,049.00 $5,764,710.00 $8,269,095.00 $1,211,577.00 -- $696,429.00 -- -- --
Accounts Payable $4,633,534.00 $3,113,025.00 $2,373,276.00 $2,521,857.00 $1,737,013.00 $527,203.00 $4,006,473.00 -- $2,509,350.00 -- -- --
Accrued Liabilities $1,652,270.00 $779,349.00 $986,437.00 $534,600.00 $666,449.00 $665,648.00 $650,753.00 -- $562,465.00 -- -- --
Total Current Liabilities $10,680,204.00 $6,556,963.00 $5,995,804.00 $6,099,523.00 $5,222,322.00 $4,020,140.00 $10,195,634.00 -- $6,867,379.00 -- -- --
Long Term Debt -- -- -- -- -- -- $113,130.00 -- -- -- -- --
Additional Paid-in Capital -- -- -- -- -- -- -- -- -- -- -- --
Accumulated Other Comprehensive Loss $-158,071.00 $-66,225.00 $-50,791.00 $-32,712.00 $-151,739.00 $-179,853.00 $-19,381.00 -- $-18,698.00 -- -- --
Accumulated Deficit $-70,373,484.00 $-65,814,193.00 $-58,201,455.00 $-50,346,584.00 $-41,705,775.00 $-34,363,039.00 $-29,759,697.00 -- $-26,898,262.00 -- -- --
Total Stockholders' Equity $-8,833,563.00 $-4,286,817.00 $3,280,839.00 $-4,041,474.00 $542,388.00 $4,248,955.00 $-8,984,057.00 $-7,333,640.00 $-6,170,950.00 -- $-8,813,709.00 $-7,717,453.00
Controlling Interest in Subsidiaries -- -- -- -- -- -- -- -- -- -- -- --
Total Liabilities and Equity $1,846,641.00 $2,270,146.00 $9,276,643.00 $2,058,049.00 $5,764,710.00 $8,269,095.00 $1,211,577.00 -- $696,429.00 -- -- --

Statement of Operations

Date 12/31/2023 6/30/2023 12/31/2022 6/30/2022 12/31/2021 6/30/2021 12/31/2020 6/30/2020 12/31/2019 3/31/2019 12/31/2018 12/31/2017
Total Revenues -- -- -- -- -- -- -- -- -- -- -- --
Cost of Revenues -- -- -- -- -- -- -- -- -- -- -- --
Gross Profit -- -- -- -- -- -- -- -- -- -- -- --
Research and Development $5,908,288.00 $4,383,625.00 $8,976,643.00 $5,544,093.00 $5,919,452.00 $1,862,735.00 $99,580.00 $41,421.00 $897,788.00 -- $708,455.00 --
Selling, General, and Administrative -- -- -- -- -- -- -- -- -- -- -- --
Total Operating Expenses $11,807,063.00 $7,549,483.00 $15,482,364.00 $8,688,026.00 $11,860,621.00 $4,542,753.00 $2,299,370.00 $1,081,694.00 $4,197,039.00 -- $3,448,861.00 --
Loss from Operations $-11,807,063.00 $-7,549,483.00 $-15,482,364.00 $-8,688,026.00 $-11,860,621.00 $-4,542,753.00 $-2,299,370.00 $-1,081,694.00 $-4,197,039.00 -- $-3,448,861.00 --
Loss Before Income Taxes -- -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Basic $-0.32 $-0.20 $-0.84 $-0.54 -- -- -- -- -- -- -- --
Weighted Average Shares Basic 38,176,020 38,176,020 19,682,643 15,892,327 -- -- -- -- -- -- -- --
Earnings Per Share Diluted $-0.32 $-0.20 $-0.84 $-0.54 -- -- -- -- -- -- -- --
Weighted Average Shares Diluted 38,176,020 38,176,020 19,682,643 15,892,327 -- -- -- -- -- -- -- --
Common Stock Shares Authorized -- 35,671,780 -- 29,346,768 -- 17,945,915 10,440,000 -- 10,440,000 -- -- --
Common Stock Shares Outstanding 35,671,780 35,671,780 32,428,893 17,785,920 6,960,000 12,068,325 6,960,000 -- 6,960,000 -- -- --
Common Stock Value $733,413.00 $733,413.00 $668,555.00 $411,268.00 $344,445.00 $259,729.00 $145,139.00 -- $145,139.00 -- -- --
Common Stock Par Or Stated Value Per Share $0.02 $0.02 $0.02 $0.02 $0.02 $0.02 $0.02 -- $0.02 -- -- --
Payments Of Dividends Common Stock -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Authorized -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Outstanding -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Value -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Par Or Stated Value Per Share -- -- -- -- -- -- -- -- -- -- -- --
Share Price $0.59 $1.10 $1.29 -- -- -- -- -- -- $14.00 -- --
Copyright 2024 PursePoor.com